Lawrence A. Dunn

Proof-of-Concept Trial with the Neurosteroid Pregnenolone Targeting Cognitive and Negative Symptoms in Schizophrenia

Richard S.E. Keefe, Robert W. Buchanan, Robert M. Hamer et al. · Neuropsychopharmacology · 2009 · 190 citations · Full text

Proof-of-concept Trial, Psychoactive Drug, Psychiatry +14

Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action

Lawrence A. Dunn, Gail E. Atwater, Clinton D. Kilts · Psychopharmacology · 1993 · 172 citations

Psychotropic Medication, Inhibitory Process, Psychopharmacology +16

Some properties of binary aqueous liquid mixtures. Apparent molar volumes and heat capacities at 298.15 K over the whole mole fraction range

C. de Visser, W. J. M. Heuvelsland, Lawrence A. Dunn et al. · Journal of the Chemical Society Faraday Transactions 1 Physical Chemistry in Condensed Phases · 1978 · 156 citations

Chemical Thermodynamics, Engineering, Molecular Thermodynamics +15

Apparent molar volumes of electrolytes. Part 3.—Some 1-1 and 2-1 electrolytes in aqueous solution at 0, 5, 15, 35, 45, 55 and 65 °C

Lawrence A. Dunn · Transactions of the Faraday Society · 1968 · 85 citations

Materials Science, Electrolytes, Chemical Engineering +15

Haloperidol enhancement of latent inhibition: Relation to therapeutic action?

George W. Christison, Gail E. Atwater, Lawrence A. Dunn et al. · Biological Psychiatry · 1988 · 84 citations

Psychiatry, Medicine, Psychopharmacology +6